We are live on ! Find out more
REFR icon

Research Frontiers

36 hedge funds and large institutions have $21M invested in Research Frontiers in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

121% more call options, than puts

Call options by funds: $161K | Put options by funds: $73K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less capital invested

Capital invested by funds: $23.4M → $21M (-$2.37M)

12% less funds holding

Funds holding: 4136 (-5)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
36
Holders Change
-5
Holders Change %
-12.2%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
12
Reduced
4
Closed
6
Calls
$161K
Puts
$73K
Net Calls
+$88K
Net Calls Change
+$310K

REFR Hedge Fund Activity: Q4 2014 in Review

36 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Research Frontiers (REFR) for Q4 2014, worth a combined $21M — down 10% from $23.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of REFR and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 12 added.

The largest buyer was Sophrosyne Capital, opening a new position worth an estimated $413K. The largest seller was Fidelity Investments, cutting an estimated $256K.

  • 36 institutional investors held Research Frontiers (REFR) as of Q4 2014, down from 41 in Q3 2014.
  • Funds reported $21M of Research Frontiers stock for Q4 2014, down 10% quarter-over-quarter.
  • 3 funds opened new Research Frontiers positions in Q4 2014 and 6 closed out, a net change of -3 holders.
  • The largest Research Frontiers buyer in Q4 2014 was Sophrosyne Capital, an estimated $413K added.
  • The largest Research Frontiers seller in Q4 2014 was Fidelity Investments, an estimated $256K sold.

Based on aggregated 13F filings for Q4 2014.